Sushil Patel

Sushil Patel is the current Chief Commercial Officer (CCO) at Replimune. Sushil has held this position for 1 year and 3 months. Prior to Replimune, Patel was with Genentech for 19 years where they held various positions such as Franchise Head Lung & Rare Cancers, Lifecycle Leader, Tecentriq Lung, International Business Leader (IBL), Division Sales Manager, Rituxan Hematology, Director, Avastin Franchise Management, Group Product Manager, Senior Publication Planning Manager.

Patel started their career as a Senior Consultant at Front Line Strategic Management Consulting for 3 years. Sushil then transitioned to Senior Research Executive at IMS Health in the Pharma Strategy Group for another 3 years. Their final role before Genentech was as a Clinical Research Scientist at Central Public Health Laboratory for 3 years.

Sushil Patel has a PhD from the University of London in Molecular Biology, which they obtained in 1999. Sushil also has an MS from Imperial College London in Biotechnology, which they obtained in 1993. Finally, they have a BS from the University of Warwick in Microbiology and Microbial Technology, which they obtained in 1992.